Monday, October 30, 2023 8:52:10 AM
Investors in $HEM are still waiting for any positive financial data to emerge, but so far, it's been a disappointing journey.
Bearish
Recent HMTXF News
- Hemostemix Leadership Attending Abundance360 Summit • Newsfile • 03/09/2026 03:23:00 PM
- Hemostemix Appoints Renowned Vascular Surgeon and Principal Investigator, Dr. York Hsiang, as Business Consultant to Advance First Nations-Led Healthcare Partnerships • Newsfile • 02/03/2026 01:55:00 PM
- Hemostemix Receives FDA Support for Its Basket Protocol Approach • Newsfile • 01/16/2026 05:26:00 PM
- Hemostemix Closes $480,000 Private Placement at $0.12 per Share • Newsfile • 12/31/2025 07:38:00 PM
- Hemostemix Appoints Dr. David B. Alper, to Lead Multidisciplinary Physician Education in the Use of ACP-01 • Newsfile • 12/23/2025 02:10:00 PM
- Hemostemix CEO Introduces Conformal Consciousness Hypothesis A = E/(hv) • Newsfile • 12/11/2025 02:40:00 PM
- Hemostemix Grants Stock Options • Newsfile • 12/11/2025 01:57:00 PM
- Hemostemix Inc. Announces FDA Pre-IND Meeting and NBPP of $960,000 • Newsfile • 12/10/2025 04:17:00 PM
- Hemostemix Welcomes Shaune Harding, OStJ, RN as Director of Patient Care & Clinical Operations • Newsfile • 12/04/2025 02:10:00 PM
- Hemostemix Featured at Innovations in Wound Healing 2025, Key West, December 11-14 • Newsfile • 12/03/2025 07:05:00 PM
- Hemostemix to Attend DFCon San Antonio and Closed its Private Placement • Newsfile • 12/02/2025 02:10:00 PM
- Hemostemix Starts its Roll-up of Cardiology Practices, Acquiring its First Two • Newsfile • 11/26/2025 09:21:00 PM
- Dr. William R. Shankle to Advance ACP-01 as a Treatment for Vascular Dementia • Newsfile • 11/20/2025 02:00:00 PM
- Hemostemix Closes CDN$280,594 Private Placement • Newsfile • 11/18/2025 10:08:00 PM
- Hemostemix to Showcase Breakthrough Wound Healing Therapy at Innovations in Wound Care Conference Florida • Newsfile • 11/18/2025 04:30:00 PM
- Hemostemix Presents ACP-01 Data at University of Florida Grand Rounds: Highlights Strong Safety, Functional Gains, and Florida Access Pathway • Newsfile • 11/13/2025 03:57:00 PM
- Hemostemix Closes Private Placement of $461,230 • Newsfile • 11/04/2025 08:09:00 PM
- Hemostemix's Boots on the Ground in Florida October Update • Newsfile • 10/30/2025 03:29:00 PM
- Hemostemix Announces Its Webinar for Florida Vascular Surgeons: Autologous Stem Cell Therapy for CLTI • Newsfile • 10/28/2025 07:44:00 PM
- Hemostemix Granted Trademark "KNOW YOUR HEALTH" in Japan, International Registration No. 1744775 Covers Stem Cell Preparations and Research in Classes 1, 5, 42 • Newsfile • 10/22/2025 02:04:00 PM
- Hemostemix Adds the Treatment of Refractory Angina to Its Phase 1 Basket Protocol • Newsfile • 10/15/2025 07:51:00 PM
- Hemostemix Files for Ethics Approval of its Study of Vascular Dementia • Newsfile • 10/09/2025 01:03:00 PM
- Hemostemix's Insider Lead Order of $330,000 Private Placement • Newsfile • 10/07/2025 02:05:00 PM
- Hemostemix Files FDA Submission for Basket Protocol (Filing 1517) to Advance ACP-01 (VesCell(TM)) Across Multiple Ischemic and Vascular Indications Simultaneously • Newsfile • 09/23/2025 04:22:00 PM
- Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 09/18/2025 12:35:00 PM
